Soy milk consumption, inflammation, coagulation, and oxidative stress among type 2 diabetic patients with nephropathy

Maryam Sadat Miraghajani, Ahmad Esmaillzadeh, Mojgan Mortazavi Najafabadi, Maryam Mirlohi, Leila Azadbakht, Maryam Sadat Miraghajani, Ahmad Esmaillzadeh, Mojgan Mortazavi Najafabadi, Maryam Mirlohi, Leila Azadbakht

Abstract

Objective: To determine the effects of soy milk consumption compared with cow's milk on inflammation, coagulation, and oxidative stress among patients with diabetic nephropathy.

Research design and methods: This randomized, crossover clinical trial was conducted on 25 type 2 diabetic patients with nephropathy. This study had two trial phases, each for 4 weeks and one washout period for 2 weeks. Patients were randomly assigned to consume a diet containing soy milk or a diet containing cow's milk.

Results: Soy milk consumption resulted in a significant reduction in d-dimer level (percent change: -3.77 vs. 16.13%; P < 0.05). This significant effect remained even after adjusting for confounding factor (carbohydrate intake). However, soy milk consumption had no significant effects on tumor necrosis factor-α, interleukin-6, high-sensitivity C-reactive protein (hs-CRP), and malondialdehyde levels. The result was near to significance regarding the effect of soy milk consumption on hs-CRP (percent change: -35.45 vs. 36.76%; P = 0.05). However, this effect was not significant after adjusting for the confounding variable (carbohydrate intake).

Conclusions: Soy milk consumption could decrease serum d-dimer level among type 2 diabetic patients with nephropathy. However, markers of inflammation and oxidative stress did not change following soy milk intake among these patients.

Trial registration: ClinicalTrials.gov NCT01419912.

Figures

Figure 1
Figure 1
Patient flow diagram.

References

    1. Yamagishi S, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev 2010;3:101–108
    1. Choudhary N, Ahlawat RS. Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy: new evidence linking inflammation, glycemic control, and microalbuminuria. Iran J Kidney Dis 2008;2:72–79
    1. Madan R, Gupt B, Saluja S, Kansra UC, Tripathi BK, Guliani BP. Coagulation profile in diabetes and its association with diabetic microvascular complications. J Assoc Physicians India 2010;58:481–484
    1. Kang YS, Lee MH, Song HK, et al. CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice. Kidney Int 2010;78:883–894
    1. Alwakeel JS, Isnani AC, Alsuwaida A, et al. Factors affecting the progression of diabetic nephropathy and its complications: a single-center experience in Saudi Arabia. Ann Saudi Med 2011;31:236–242
    1. Azadbakht L, Esmaillzadeh A. Red meat intake is associated with metabolic syndrome and the plasma C-reactive protein concentration in women. J Nutr 2009;139:335–339
    1. Azadbakht L, Surkan PJ, Esmaillzadeh A, Willett WC. The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. J Nutr 2011;141:1083–1088
    1. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care 2007;30:967–973
    1. Galland L. Diet and inflammation. Nutr Clin Pract 2010;25:634–640
    1. Pot GK, Geelen A, Majsak-Newman G, et al. Increased consumption of fatty and lean fish reduces serum C-reactive protein concentrations but not inflammation markers in feces and in colonic biopsies. J Nutr 2010;140:371–376
    1. Bhupathiraju SN, Tucker KL. Greater variety in fruit and vegetable intake is associated with lower inflammation in Puerto Rican adults. Am J Clin Nutr 2011;93:37–46
    1. Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 2008;31:648–654
    1. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Dietary soya intake alters plasma antioxidant status and lipid peroxidation in postmenopausal women with the metabolic syndrome. Br J Nutr 2007;98:807–813
    1. Sugimoto S, Fujii T, Morimiya T, Johdo O, Nakamura T. The fibrinolytic activity of a novel protease derived from a tempeh producing fungus, Fusarium sp. BLB. Biosci Biotechnol Biochem 2007;71:2184–2189
    1. Huang G, Liu Y, Chang H, et al. Effects of genistein on oxidative injury in endothelial cells. J Nutr Sci Vitaminol (Tokyo) 2008;54:402–408
    1. Mateos-Aparicio I, Redondo Cuenca A, Villanueva-Suárez MJ, Zapata-Revilla MA. Soybean, a promising health source. Nutr Hosp 2008;23:305–312
    1. Franke AA, Ashburn LA, Kakazu K, Suzuki S, Wilkens LR, Halm BM. Apparent bioavailability of isoflavones after intake of liquid and solid soya foods. Br J Nutr 2009;102:1203–1210
    1. Nutritional care in renal disease. In Applications in Medical Nutrition Therapy. 2nd edZeman FJ, Ney DM, Eds. New Jersey, Prentice Hall, 1996, p. 276
    1. Meyers BD, Bennett PH. Clinical evolution of renal disease in insulin dependent and noninsulin dependent diabetes mellitus. In Principles and Practice of Nephrology. 1st ed Jacobson HR, Striker, GE, Klahr, S, Eds. Philadelphia, BC Decker, 1991, p. 464
    1. Fleiss JL. The Design and Analysis of Clinical Experiments. London, John Wiley and Sons, 1986, p. 263–271
    1. Institute of Medicine Food and Nutrition Board: Dietary Reference Intake for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC, National Academies Press, 2002
    1. Kleyn DH, Lynch JM, Barbano DM, Bloom MJ, Mitchell MW. Determination of fat in raw and processed milks by the Gerber method: collaborative study. J AOAC Int 2001;84:1499–1508
    1. Faerk J, Skafte L, Petersen S, Peitersen B, Michaelsen KF. Macronutrients in milk from mothers delivering preterm. Adv Exp Med Biol 2001;501:409–413
    1. Nozawa S, Hakoda A, Sakaida K, Suzuki T, Yasui A. Method performance study of the determination of total nitrogen in soy sauce by the Kjeldahl method. Anal Sci 2005;21:1129–1132
    1. Díaz-Castelazo C, Rico-Gray V, Ortega F, Angeles G. Morphological and secretory characterization of extra floral nectaries in plants of coastal Veracruz, Mexico. Ann Bot 2005;96:1175–1189
    1. Dong JY, Wang P, He K, Qin LQ. Effect of soy isoflavones on circulating C-reactive protein in postmenopausal women: meta-analysis of randomized controlled trials. Menopause 2011;18:1256–1262
    1. Nasca MM, Zhou JR, Welty FK. Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol 2008;102:84–86
    1. Wakabayashi I, Masuda H. Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus. J Thromb Thrombolysis 2009;27:29–35
    1. Imani H, Tabibi H, Atabak S, Rahmani L, Ahmadinejad M, Hedayati M. Effects of soy consumption on oxidative stress, blood homocysteine, coagulation factors, and phosphorus in peritoneal dialysis patients. J Ren Nutr 2009;19:389–395
    1. Huang Y, Cao S, Nagamani M, Anderson KE, Grady JJ, Lu LJ. Decreased circulating levels of tumor necrosis factor-alpha in postmenopausal women during consumption of soy-containing isoflavones. J Clin Endocrinol Metab 2005;90:3956–3962
    1. Rashidi A, Nakhjavani M, Esteghamati A, et al. Association between oxidant/antioxidant markers and proteinuria in type 2 diabetes: results in 142 patients. J Nephrol 2009;22:733–738
    1. Kano M, Takayanagi T, Harada K, Sawada S, Ishikawa F. Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. J Nutr 2006;136:2291–2296
    1. Nielsen IL, Williamson G. Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer 2007;57:1–10
    1. Rau De Almeida Callou K, Sadigov S, Lajolo FM, Genovese MI. Isoflavones and antioxidant capacity of commercial soy-based beverages: effect of storage. J Agric Food Chem 2010;58:4284–4291
    1. Tamura A, Shiomi T, Hachiya S, Shigematsu N, Hara H. Low activities of intestinal lactase suppress the early phase absorption of soy isoflavones in Japanese adults. Clin Nutr 2008;27:248–253

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe